System Status Messages

Time Market Status
19:32:30 ETNASDAQ
BX
Post - Trade
PSX
NASDAQ Options
BX Options
PHLX
NASDAQ Futures
ISE
GEMX
MRX
Systems are operating normally

Regulatory Messages

Time Market Status
19:32:30 ETNASDAQ
BX
PSX
NASDAQ Options
BX Options
NASDAQ Futures
ISE
GEMX
MRX
There are no messages available

IPO Messages

Time Market Status
11:56:21 ETNASDAQ

IPO Notice Update: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.




11:51:39 ETNASDAQ

IPO Notice Update: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.





11:46:05 ETNASDAQ

IPO Notice Update: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.




11:41:30 ETNASDAQ

IPO Notice Update: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.





11:30:04 ETNASDAQIPO Notice Update: The initial public offering of security, Pioneer Bancorp, Inc. (PBFS) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.


11:25:01 ETNASDAQIPO Notice Update: The initial public offering of security, Pioneer Bancorp, Inc. (PBFS) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.


11:20:41 ETNASDAQIPO Notice Update: The initial public offering of security, Pioneer Bancorp, Inc. (PBFS) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.


11:15:03 ETNASDAQIPO Notice Update: The initial public offering of security, Pioneer Bancorp, Inc. (PBFS) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.


11:10:01 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:05:02 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



11:00:01 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:55:21 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:50:00 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:45:01 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:40:11 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:40:10 ETNASDAQIPO Notice Update: The initial public offering of Genmab A/S American Depositary Shares (GMAB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:35:14 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:30:58 ETNASDAQIPO Notice Update: The initial public offering of Genmab A/S American Depositary Shares (GMAB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:30:01 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:25:17 ETNASDAQIPO Notice Update: The initial public offering of security, FULC - Fulcrum Therapeutics, Inc., remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:20:54 ETNASDAQIPO Notice Update: The initial public offering of Genmab A/S American Depositary Shares (GMAB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



10:10:21 ETNASDAQIPO Notice Update: The initial public offering of Genmab A/S American Depositary Shares (GMAB) remains in Pre-Launch status pending additional price discovery and is anticipated to open for trading shortly. All NASDAQ systems are fully operational. Please refer to the NOII – Net Order Imbalance Indicator for updates on indicated price and cross volume. For additional information you can contact the Trading Services desk at 212 231-5100. Reminder: Trading is prohibited during quote-only period of IPOs.



09:12:19 ETNASDAQIPO Notice: The initial public offering of Mirum Pharmaceuticals, Inc. (MIRM) will be released on Nasdaq today for quotation at 11:25 a.m. ET and will be eligible for trading at approximately 11:35 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.

09:00:19 ETNASDAQIPO Notice: The initial public offering of Pioneer Bancorp, Inc. (PBFS) will be released on Nasdaq today for quotation at 11:00 a.m. ET and will be eligible for trading at approximately 11:10 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.

08:50:20 ETNASDAQIPO Notice: The initial public offering of Fulcrum Therapeutics, Inc. (FULC) will be released on Nasdaq today for quotation at 10:10 a.m. ET and will be eligible for trading at approximately 10:20 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.

08:27:43 ETNASDAQIPO Notice: The initial public offering of Conyers Park II Acquisition Corp. Units (CPAAU) will be released on Nasdaq today for quotation at 10:35 a.m. ET and will be eligible for trading at approximately 10:45 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.

08:03:31 ETNASDAQIPO Notice: The initial public offering of Genmab A/S American Depositary Shares (GMAB) will be released on Nasdaq today for quotation at 09:50 a.m. ET and will be eligible for trading at approximately 10:00 a.m. ET. Orders are now being accepted. Please call 877-308-0523 if you have any questions. Reminder: Trading is prohibited during quote-only period of IPOs.


Self-Help Messages

Time Market Status
19:32:30 ETNASDAQ
BX
PSX
NASDAQ Options
NASDAQ Futures
BX Options
PHLX
ISE
GEMX
MRX
There are no messages available